Hims & Hers Health, Inc.

NYSE:HIMS

Medical - Equipment & Services

Healthcare
$17.05 +3.47%

+$1.11 today

Market cap
$3.85B
Beta
2.40
P/E (TTM)
-569.3
EPS (TTM)
-$0.06
52W Low $13.74High $70.43

Volume 9.53M

Average 26.18M

HIMS Sales of Investments

Cash received from selling or redeeming investments.

Hims & Hers Health, Inc.NYSE: HIMS

Sales of Investments · Q3 FY2026 · quarter ended Sep 2026

Sales of investments growth accelerates

Q3 FY2026 sales of investments of $157.93M rose 1195.7% year over year, ahead of the +615.2% change in trailing-twelve-month sales of investments. Sequentially, it fell 46.8% from the prior quarter. Over 3 fiscal years it compounded at -22.1% a year.

Context

  • Sales of investments amounted to 4.6% of revenue in FY2025, down 9.6 pp from a year earlier.
  • Sales of investments increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1195.7% holds above the trailing-twelve-month pace of +615.2%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$157.93M-46.8% QoQ
Last fiscal yearDec 2025
$108.7M-48.2% YoY
LTMSep 2026
$660.86M+615.2% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1195.7%——
1 year-48.2%——
3-year CAGR-22.1%——
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
108.7M USD
Year-over-year change
-48.2%
4-year CAGR
-9.5%

Sales of Investments vs competitors

How HIMS compares with its peers on the latest reported figures

  • HIMS's LTM Sep 2026 sales of investments of $660.86M is the 2nd largest of the 10 companies compared; the peer median is $0.
  • Its year-over-year change of +615.2% is the highest of 2, against a peer median of -100.0%.
  • Sales of investments amounts to 23.0% of revenue for HIMS, versus a peer median of 0.0%.
HIMS Competitors Peer median
Sales of Investments for HIMS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
COTYCoty Inc.LTM Sep 2026$750M ——13.0%
HIMSHims & Hers Health, Inc.LTM Sep 2026$660.86M +615.2%-22.1%23.0%
ELThe Estée Lauder Companies Inc.LTM Sep 2026$0 -100.0%—0.0%
KVUEKenvue Inc.LTM Sep 2026$0 ——0.0%
ELFe.l.f. Beauty, Inc.LTM Jun 2026$0 ——0.0%
PRGOPerrigo Company plcLTM Jun 2026$0 ——0.0%
EPCEdgewell Personal Care CompanyLTM Mar 2026$0 ——0.0%
HELEHelen of Troy LimitedLTM Dec 2025$0 ———
HNSTThe Honest Company, Inc.LTM Mar 2026$0 ——0.0%
LFMDLifeMD, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding HIMS) $0-100.0%—0.0%

Competitors are the stored peer set for HIMS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(107.66M)(65.68M)(23.55M)126.04M128.37M
Depreciation & Amortization4.08M7.47M9.52M17.09M54.5M
Deferred Income Tax(3.39M)(594K)(13K)(61.65M)(12.96M)
Stock-Based Compensation67.21M42.82M66.08M92.32M135.24M
Change in Working Capital3.46M(14.2M)20.82M78.62M(29.16M)
Accounts Receivables00000
Inventory(9.63M)(8M)(902K)(41.61M)(13.72M)
Accounts Payables9.85M12.72M7.32M43.71M30.3M
Other Working Capital3.23M(18.91M)14.4M76.53M(45.74M)
Other Non-Cash Items1.89M3.65M626K(1.34M)24.02M
Operating Cash Flow(34.41M)(26.53M)73.48M251.08M300.01M
Capital Expenditures(5.01M)(7.25M)(26.49M)(52.75M)(226.05M)
Acquisitions (Net)(46.47M)(459K)0(15.4M)(145.23M)
Purchases of Investments(266.63M)(187.7M)(157.24M)(160.56M)(745.84M)
Sales of Investments161.84M230.11M171.63M209.67M108.7M
Other Investing Activities(4.18M)(4.53M)(9.27M)(11.1M)(16.55M)
Investing Cash Flow(156.27M)34.7M(12.11M)(19.05M)(1.02B)
Debt Repayment1.19M000918.78M
Common Stock Issued272.69M00017.47M
Common Stock Repurchased(22.03M)0(2M)(83.04M)(89.96M)
Dividends Paid00000
Other Financing Activities(16.81M)(33.13M)(9.48M)(24.81M)(116.67M)
Financing Cash Flow235.04M(33.13M)(11.48M)(107.85M)729.62M
Effect of Forex Changes(73K)(53K)(11K)(270K)3.36M
Net Change in Cash44.29M(25.01M)49.89M123.92M8.03M
Free Cash Flow(39.42M)(33.78M)46.99M198.33M73.96M

Hims & Hers Health, Inc.

NYSE:HIMS

Intrinsic Alpha fair value

Locked

Current Price

$17.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.